Ferring is exploring the links between recent Nobel Prize winning…

Infertility experts from around the world gather to review the newest breakthroughs including…

The new data was based on a sub-analysis of the landmark trial EISG (European-Israeli Study Group) which was designed to demonstrate non-inferiority of MENOPUR (HP-hMG) when compared with rFSH in nearly 700 IVF and ICSI patients…

The acquisition reinforces Ferring’s commitment to Latin America and strengthens the company in the field of women’s health…

Ferring announced today the closing of a deal with Novartis Pharma AG for the acquisition of the worldwide manufacturing, marketing and distribution rights of NORPROLAC (quinagolide)…

Over one million Europeans suffer from IBD, or inflammatory bowel disease of the colon and rectum…

New results from a large multicenter study indicate that women undergoing IVF treatment with MENOPUR have a remarkable improved chance of becoming pregnant vs. women treated with recombinant FSH…

Earlier this month, Ferring Pharmaceuticals granted the Dr. Frederik Paulsen Memorial Award in Neurosciences. The award winner, Dr. Yamashita from the Tokyo Medical and Dental University, received the award for…

Ferring Pharmaceuticals, world pioneer and leader in industrial synthetic peptides, breaks ground for a new manufacturing site in Saint-Prex, canton of Vaud. The company will invest…